| 000 | 01378 a2200325 4500 | ||
|---|---|---|---|
| 001 | 1351648411 | ||
| 005 | 20250317111557.0 | ||
| 008 | 250312042017xx 84 eng | ||
| 020 | _a9781351648417 | ||
| 037 |
_bTaylor & Francis _cGBP 47.99 _fBB |
||
| 040 | _a01 | ||
| 041 | _aeng | ||
| 072 | 7 |
_aPSD _2thema |
|
| 072 | 7 |
_aTBN _2thema |
|
| 072 | 7 |
_aTDCW _2thema |
|
| 072 | 7 |
_aPSD _2bic |
|
| 072 | 7 |
_aTBN _2bic |
|
| 072 | 7 |
_aTDCW _2bic |
|
| 072 | 7 |
_aMED072000 _2bisac |
|
| 072 | 7 |
_aSCI010000 _2bisac |
|
| 072 | 7 |
_aSCI049000 _2bisac |
|
| 072 | 7 |
_aSCI086000 _2bisac |
|
| 072 | 7 |
_a610.28 _2bisac |
|
| 100 | 1 | _aBertrand Henri Rihn | |
| 245 | 1 | 0 | _aBiomedical Application of Nanoparticles |
| 250 | _a1 | ||
| 260 |
_bCRC Press _c20170905 |
||
| 300 | _a348 p | ||
| 520 | _bBiomedical Application of Nanoparticles explores nanoparticles, their chemical and physicals properties, and how they interact in biological systems with proteins, immune system and targeted cells. Risk assessment of nanoparticles for human is described, including: cellular paradigms, transcriptomics and toxicogenomics. Finally, the applications of nanoparticles in medicine and antioxidant regenerative therapeutics are presented in several chapters with emphasis on how nanoparticles enhance transport of drugs across biological membrane barriers and therefore may enhance drug bioavailability. | ||
| 999 |
_c3763 _d3763 |
||